Aurovela Fe Kit
Product Images NDC 65862-941

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Aurovela Fe (NDC 65862-941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Norethindroneethinyl Fig1)

A bar chart illustrating mortality rates (number of deaths per 100,000 women users) across different age groups among ever-users and controls of a treatment, separated by smoking status. The age groups shown are 15–24, 25–34, 35–44, and 45 and older, with mortality rates increasing notably in older age groups, especially among ever-users who smoke.*

FDA Label Image

Figure-2 (Norethindroneethinyl Fig2)

A forest plot comparing effect estimates for 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' across several studies. The x-axis represents effect estimates from -1.50 to 2.00. Individual study results are shown with point estimates and confidence intervals, along with corresponding odds ratios or relative risks on the right side.*

FDA Label Image

Figure-3 (Norethindroneethinyl Fig3)

An illustrated dosing chart for AUROVELA Fe 1.5/30 kit with norethindrone acetate, ethinyl estradiol, and ferrous fumarate tablets. The chart shows a 4-week weekly layout of circular pill slots labeled by days from Sunday to Saturday. Instructions indicate starting points for Sunday starters and day-1 starters, including placement of a day label sticker if the period begins on a day other than Sunday. Arrows guide pill intake direction from left to right for each week.*

FDA Label Image

Package Label-principal Display Panel (1.5 mg/30 mcg and 75 mg Pouch Label)

An instructional dosing diagram for AUROVELA Fe 1.5/30 kit with norethindrone acetate, ethinyl estradiol, and ferrous fumarate tablets. It shows a weekly pill layout labeled Sunday through Saturday with four weekly rows. Instructions indicate where to start for Sunday and Day-1 starters, how to apply day label stickers, and the direction for taking pills from left to right each week. The diagram notes to take white to off-white pills before brown pills.*

FDA Label Image

Package Label-principal Display Panel (1.5 mg/30 mcg and 75 mg Blister Carton)

Packaging label for AUROVELA Fe 1.5/30 kit, containing norethindrone acetate and ethinyl estradiol tablets, USP, and ferrous fumarate tablets. The label indicates a 28-tablet pouch and a 28-day specimen kit. It is a prescription drug distributed by Aurobindo Pharma Limited and includes usage warnings and storage instructions.*

FDA Label Image

Norethindroneethinyl Fig6

Packaging label for AUROVELA Fe 1.5/30 kit containing norethindrone acetate and ethinyl estradiol tablets with ferrous fumarate tablets. The label indicates the product includes three 28-tablet pouches, with each pouch containing 21 active tablets and 7 ferrous fumarate tablets. Distributed by Aurobindo Pharma Limited, the label also provides the NDC 65862-941-81 and storage instructions.*

FDA Label Image

Chemical Structure1 (Norethindroneethinyl Str1)

Chemical structure of norethindrone acetate, an active ingredient in AUROVELA Fe, depicting its steroidal backbone with acetate and alkyne functional groups.*

FDA Label Image

Chemical Structure2 (Norethindroneethinyl Str2)

Chemical structure of Ethinyl Estradiol, shown with labeled bonds and hydroxyl groups, representing its molecular configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.